BiondVax Pharmaceuticals Ltd.
Earnings Date & Report
Last updated:
BiondVax Pharmaceuticals Ltd.’s last earnings date was on 17 Apr 2023. It reported its quarterly earnings per share (EPS) reaching -$0.3, matching the estimated value of -$0.3.
BiondVax Pharmaceuticals Ltd. stock Earnings report, Estimates & History
| 2018-11-13 | -1.1 | -1.1 |
|---|---|---|
| 2018-12-31 | -499.25104 | -70.05443 |
| 2019-04-30 | -0.1 | -0.5 |
| 2019-05-30 | 0.2 | 0.2 |
| 2019-08-28 | -2060.4 | -20.2 |
| 2019-11-26 | -152.00019 | -5.7 |
| 2019-12-31 | -660.48875 | -42.11096 |
| 2020-06-30 | -8 | -0.8 |
| 2020-08-20 | -1276.8 | -11.2 |
| 2020-09-30 | 362.21 | 41.09 |
| 2021-01-28 | -0.1 | -0.1 |
| 2021-06-23 | -1.9 | -1.9 |
| 2021-08-26 | -3.7 | -3.7 |
| 2021-11-30 | -139.10845 | -6.31257 |
| 2022-03-28 | -4.24242 | -1.33556 |
| 2022-06-01 | -4 | -2 |
| 2022-08-25 | -0.40005 | -2.1 |
| 2022-11-30 | -0.006 | 0.06 |
| 2023-04-17 | -0.3 | -0.3 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
BiondVax Pharmaceuticals Ltd. stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 17 Apr 2023 | Matched | -$0.3 | -$0.3 | N/A | N/A | |
| 30 Nov 2022 | Beat | -$0.01 | $0.06 | -4.30M | N/A | |
| 25 Aug 2022 | Missed | -$0.4 | -$2.1 | 10.30M | N/A | |
| 1 Jun 2022 | Beat | -$4 | -$2 | -15.96M | N/A | |
| 28 Mar 2022 | Beat | -$4.24 | -$1.34 | -33.30M | N/A | |
| 30 Nov 2021 | Beat | -$139.11 | -$6.31 | -222.37M | N/A | |
| 26 Aug 2021 | Matched | -$3.7 | -$3.7 | -542.52M | N/A | |
| 23 Jun 2021 | Matched | -$1.9 | -$1.9 | -174.25M | N/A | |
| 13 May 2021 | N/A | N/A | N/A | N/A | N/A | |
| 28 Jan 2021 | Matched | -$0.1 | -$0.1 | -308.31M | N/A | |
| 30 Sep 2020 | Missed | $362.21 | $41.09 | 447.05M | N/A | |
| 20 Aug 2020 | Beat | -$1,276.8 | -$11.2 | -3.70B | N/A | |
| 30 Jun 2020 | Beat | -$8 | -$0.8 | -15.38M | N/A | |
| 31 Dec 2019 | Beat | -$660.49 | -$42.11 | -740.28M | N/A | |
| 26 Nov 2019 | Beat | -$152 | -$5.7 | -680.34M | N/A | |
| 28 Aug 2019 | Beat | -$2,060.4 | -$20.2 | -5.56B | N/A | |
| 30 May 2019 | Matched | $0.2 | $0.2 | 42.80K | N/A | |
| 30 Apr 2019 | Missed | -$0.1 | -$0.5 | N/A | N/A | |
| 31 Dec 2018 | Beat | -$499.25 | -$70.05 | -217.34M | N/A | |
| 13 Nov 2018 | Matched | -$1.1 | -$1.1 | -6.46M | N/A | |
BiondVax Pharmaceuticals Ltd. Earnings report FAQs
When is BiondVax Pharmaceuticals Ltd.'s next Earnings date?
The company has not set the next earnings date yet. The latest BiondVax Pharmaceuticals Ltd.'s earnings date was on 28 Mar 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.